Editas Medicine Inc
NASDAQ:EDIT
Editas Medicine Inc
NASDAQ:EDIT
Price:
5.95 USD
4.75%
Market Closed
Updated:
May 15, 2024
Editas Medicine Inc
Net Issuance of Common Stock
|
Editas Medicine Inc
Net Issuance of Common Stock Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Net Issuance of Common Stock Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Issuance of Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Editas Medicine Inc
NASDAQ:EDIT
|
Net Issuance of Common Stock
$118.2m
|
CAGR 3-Years
-37%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Net Issuance of Common Stock
-$1.8B
|
CAGR 3-Years
-33%
|
CAGR 5-Years
32%
|
CAGR 10-Years
N/A
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Net Issuance of Common Stock
-$768m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
20%
|
CAGR 10-Years
-2%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Net Issuance of Common Stock
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Net Issuance of Common Stock
-$293m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-37%
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Net Issuance of Common Stock
-$473.2m
|
CAGR 3-Years
51%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Editas Medicine Inc's Net Issuance of Common Stock?
Net Issuance of Common Stock
118.2m
USD
118.2m
USD
Based on the financial report for Mar 31, 2024, Editas Medicine Inc's Net Issuance of Common Stock amounts to 118.2m USD.
What is Editas Medicine Inc's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 5Y
27%
27%
Over the last year, the Net Issuance of Common Stock growth was 11 054%. The average annual Net Issuance of Common Stock growth rates for Editas Medicine Inc have been -37% over the past three years , 27% over the past five years .
You don't have any saved screeners yet
